[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.204.95.166. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
January 1995

High-Resolution Magnetic Resonance Imaging Evaluation of Blood-Retinal Barrier Integrity Following Transscleral Diode Laser Treatment

Author Affiliations

From the Department of Ophthalmology (Drs Arrindell, Wolf, Nanda, Han, Abrams, and Mieler) and the Biophysics Research Institute (Drs Wu, Wong, Abrams, and Hyde), Medical College of Wisconsin, Milwaukee. Dr Arrindell is now with the Department of Ophthalmology, Meharry Medical College, Nashville, Tenn. The authors and institutions have no proprietary interest in the diode laser or MRI hardware used in these studies.

Arch Ophthalmol. 1995;113(1):96-102. doi:10.1001/archopht.1995.01100010098027
Abstract

Objective:  To compare the effects of contact transscleral diode laser treatment and retinal cryotherapy on blood-retinal barrier integrity with the use of high-resolution magnetic resonance imaging techniques with constant infusion of gadolinium—diethylenetriaminepentaacetic acid (Gd-DTPA).

Methods:  Transscleral diode laser photocoagulation and retinal cryotherapy were used to treat equivalent areas of the inferior retinal periphery of pigmented rabbits. Magnetic resonance imaging time-course studies with measurement of signal enhancements due to Gd-DTPA leak-age were conducted 2 and 15 days following treatment.

Results:  Two days following treatment, cryotherapytreated eyes exhibited a mean (±SD) effective Gd-DTPA permeability coefficient of 4.6±0.8×10−6 cm/s; in comparison, diode laser—treated eyes exhibited 1.6×1.4×10−6 cm/s effective permeability. Significant decreases in the effective permeability were also noted 15 days after treatment in both groups.

Conclusions:  Transscleral contact probe diode laser photocoagulation induces less disruption of the blood-retinal barrier than does conventional cryotherapy. In addition, the continuous infusion method of Gd-DTPA delivery is a reliable and easily interpretable alternative to the commonly used bolus injection approach.

×